SCHEMBL5651058

SCHEMBL5651058

O=C(OC(=O)c1ccc(F)cc1F)c1ccccc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 2/20 0.52
CES1 P23141 2/20 0.52
L3MBTL1 Q9Y468 3/20 0.44
POLB P06746 2/20 0.44
MAPT P10636 2/20 0.44
TDP1 Q9NUW8 1/20 0.44
RAB9A P51151 3/20 0.43
PKM P14618 2/20 0.43
NPC1 O15118 1/20 0.43
LMNA P02545 2/20 0.43
GAA P10253 2/20 0.43
RECQL P46063 1/20 0.43
KMT2A Q03164 1/20 0.43
F2 P00734 1/20 0.42
HDAC1 Q13547 1/20 0.42
PLA2G7 Q13093 1/20 0.42
ADORA3 P0DMS8 1/20 0.41
ADORA2A P29274 1/20 0.41
ADORA1 P30542 1/20 0.41
TSHR P16473 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5651048 0.88 CES2 (0.65) CES2CES1L3MBTL1POLBMAPT
SCHEMBL8378857 0.82 KMT2A (0.53) CES2CES1L3MBTL1TDP1RAB9A
SCHEMBL28305665 0.81 ALDH1A1 (0.49) CES2CES1L3MBTL1POLBMAPT
SCHEMBL576239 0.80 KMT2A (0.39) CES2CES1POLBMAPTRAB9A
SCHEMBL775621 0.80 NPC1 (0.61) CES2CES1POLBMAPTTDP1
SCHEMBL23497897 0.79 F2 (0.45) CES2CES1POLBMAPTTDP1
SCHEMBL28637523 0.79 CES2 (0.52) CES2CES1POLBMAPTTDP1
SCHEMBL5649620 0.79 PKM (0.61) CES2CES1RAB9APKMNPC1
SCHEMBL158348 0.79 CES2 (0.59) CES2CES1L3MBTL1MAPTTDP1
SCHEMBL29765677 0.79 CES2 (0.59) CES2CES1L3MBTL1MAPTTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7235559-B1 Therapeutic quinazoline derivatives ASTRAZENECA AB (SE) 2007-06-26 US disclosed
EP-1218355-A1 THERAPEUTIC QUINAZOLINE DERIVATIVES AstraZeneca AB (SE) 2002-07-03 EP disclosed
WO-2001021597-A1 THERAPEUTIC QUINAZOLINE DERIVATIVES ASTRAZENECA AB (SE) 2001-03-29 WO disclosed
US-4255594-A Hydrogenation of halogen-containing carboxylic anhydrides ALLIED CHEMICAL CORPORATION (US) 1981-03-10 US disclosed